New Study Shows Cambridge, MA is Home to 2 of the Top 10 Fastest Growing Tech Companies in North America

The results are in and – if you didn’t know it already – Cambridge, Massachusetts is a confirmed hotbed for tech companies.

The professional services firm, Deloitte, recently released its 2011 Technology Fast 500 Rankings. These rankings looked at technology, media, telecommunications, life sciences and clean technology companies from all over North America. Deloitte selected its 500 fastest growing tech companies based on percentage fiscal year revenue growth between 2006 and 2010.

Of these 500, two companies from the Cambridge startup community made the top 10: HubSpot, which came in at #8; and ARIAD Pharmaceuticals, Inc., which came in at #10.

Founded by MIT classmates Brian Halligan and Dharmesh Shah, HubSpot is a software company that develops solutions for inbound marketing. Inbound marketing is the practice of helping your business “get found,” as opposed to interrupting potential customers with traditional forms of marketing and advertising (like cold calling and TV commercials).

HubSpot’s software platform includes applications for blogging, email marketing, landing pages, lead management, marketing analytics, search engine optimization, social media monitoring and website management. The company also develops free online tools, like the website analysis tool, WebsiteGrader.com.

While software companies, like HubSpot, make up the largest industry demographic on Deloitte’s Technology Fast 500 list, the biotechnology/pharmaceutical company, ARIAD, still managed to make it into the top 10.

ARIAD focuses on developing and commercializing small-molecule drugs for treating cancer. More specifically, the company targets aggressive cancers that current therapies are unable to treat effectively.

“Recognition by the 2011 Technology Fast 500 is an important achievement for ARIAD Pharmaceuticals as we build momentum towards becoming a global commercial oncology company,” ARIAD’s chairman and CEO, Harvey J. Berger, M.D., told New England Post in a recent statement.

Berger continued, “We are preparing for the commercial launch next year of ponatinib, our internally discovered drug candidate for chronic myeloid leukemia, and we have a robust, internally discovered cancer pipeline behind ponatinib.”

In addition to HubSpot and ARIAD, several other Massachusetts-based companies were selected for Deloitte’s 2011 Technology Fast 500 Rankings. Most notably, there were a total of 10 Massachusetts tech companies (including HubSpot and ARIAD) that made the top 100. You can check out a list of those companies below:

• #8. HubSpot – (Software) Cambridge MA
• #10. ARIAD Pharmaceuticals, Inc. – (Biotechnology/pharmaceutical) Cambridge, MA
• #29. Celldex Therapeutics, Inc. – (Biotechnology/pharmaceutical) Needham, MA
• #43. IISi – (Software) Boston, MA
• #47. Insulet Corp. – (Medical equipment) Bedford,MA
• #48. AMAG Pharmaceuticals, Inc. – (Biotechnology/pharmaceutical) Lexington, MA
• #59. pSivida Corp. – (Biotechnology/pharmaceutical) Watertown, MA
• #70. Zmags Corp. – (Software) Boston, MA
• #81. PlumChoice, Inc. – (Computers/peripherals) Billerica, MA
• #92. Satcon Technology Corp. – (Semiconductor) Boston, MA

Related posts:

1. MA Company Takes Top Spot in Science Magazine’s Employers Survey; 4 Other MA Companies Make the List
2. Buzzient Raises $$ to Build a World Class Software Company Here in Boston
3. Loco for Locu; Cambridge Startup to Launch Online Menu Service, Receives Funding From Some of the Biggest Names in Tech
4. 3 New England Companies Earn Spots On The World Economic Forum’s 2012 List of Technology Pioneers; See How It Compares To Our Previous Performances
5. A Visionary’s Farewell: The Cambridge Tech Community Says Goodbye to Steve Jobs at a Kendall Square Memorial Service

Short URL: http://www.newenglandpost.com/?p=6046

Posted by erik devaney on Oct 19 2011. Filed under Featured - For home page featured article, Technology. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry